Adi Aran, MD, a Pediatric Neurologist at one of Israel’s top hospitals, knows cannabis can help children with autism. He’s seen results with his own patients, and a recent clinical trial he conducted shows evidence of its benefits.

There is some evidence to support the use of cannabis for symptom management in children with cancer, but there is a lack of evidence on the safety and efficacy of cannabinoids in this patient population, according to researchers.

AJEM goes inside the MIND Foundation’s INSIGHT 2023 psychedelic medicine meeting.

Medical cannabis is poorly integrated into rheumatic disease care, despite being widely available, according to recent study results.

Although cannabis is known for interacting with the endocannabinoid system and psilocybin with the serotonin system, these psychoactives and vital signaling systems also interact extensively, and are areas of intense research for mental health disorders.

The story of the American Journal of Endocannabinoid Medicine (AJEM) begins in 2016. That’s when I started to notice more content on medical cannabis being presented from different sources, all with separate and distinct goals and objectives.

Medical training programs traditionally have not included much education on the endocannabinoid system or the therapeutic potential of cannabis, leading many physicians to feel unprepared to discuss these medications with their patients.

Brittney Griner’s experience in Russia has raised awareness about the usage of cannabis in sports in positive, negative, and unexpected ways.

Harvard-trained physician discusses the risk for SUD among physicians and the potential role for cannabinoid-based therapy.

An OBGYN and skilled minimally invasive surgeon provides commentary on study: Shi et al. The associations between prenatal cannabis use disorder and neonatal outcomes. Addiction. 2021;10.1111/add.15467.